FDA Drug Recalls

Recalls / Class II

Class IID-627-2013

Product

Lidocaine Hydrochloride and 5% Dextrose Injection, USP, 2g VIAFLEX Plus Plastic Container, 500mL, Rx Only, Baxter, Deerfield, IL 60015

Affected lot / code info
Lot #: Product code 2B0973: P279935, Exp 7/13

Why it was recalled

Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Recalling firm

Firm
Baxter Healthcare Corp.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, N/A, Deerfield, Illinois 60015-4625

Distribution

Quantity
N/A
Distribution pattern
Nationwide & Puerto Rico

Timeline

Recall initiated
2013-05-21
FDA classified
2013-06-28
Posted by FDA
2013-07-10
Terminated
2015-06-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-627-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls